Abort, Retry, Fail - Billionaire Bill Gates Opines, Sans Evidence, on ... the Efficacy of Hepatitis C Treatment?

conflicts of interest Gates Foundation Genentech Gilead global health health care foundations hepatitis C Sovaldi

Abort, Retry, Fail - Billionaire Bill Gates Opines, Sans Evidence, on ... the Efficacy of Hepatitis C Treatment?

Unknown 7/15/2016 Komentar

If you needed advice about the technical characteristics of computer operating systems you probably would not go to your doctor for it.  So why would you seek the opinion of a software company mogul about the efficacy...

Baca selengkapnya

Bill Clinton, Paid to Speak to Biotech Conference, Extolled $1000 Pill to Prevent "Liver Rot," Despite Lack of Evidence that It Does

Clinton Foundation evidence-based medicine Gilead hepatitis C Sovaldi

Bill Clinton, Paid to Speak to Biotech Conference, Extolled $1000 Pill to Prevent "Liver Rot," Despite Lack of Evidence that It Does

Unknown 7/02/2015 Komentar

What were they thinking?Former President Clinton Talkes to Pharma and Biotech Executives In mid June, 2015, the Philadelphia Inquirer reported that former US PresidentClinton was the keynote speaker at Klick Ideas Exchange,...

Baca selengkapnya

Logical Fallacies in Defense of Aggresive Screening for and Treatment of Hepatitis C

anechoic effect evidence-based medicine hepatitis C logical fallacies Sovaldi

Logical Fallacies in Defense of Aggresive Screening for and Treatment of Hepatitis C

Unknown 1/22/2015 Komentar

And the hepatitis C follies continue... As we have frequently written, most recently last week, the hepatitis C screening and treatment bandwagon keeps rolling along.  There is constant public argument about the prices...

Baca selengkapnya

The Fashion Challenges of the Emperor of Hepatitis C Treatment - Now in the BMJ, but Who Will Notice?

clinical trials evidence-based medicine health care prices hepatitis C Sovaldi

The Fashion Challenges of the Emperor of Hepatitis C Treatment - Now in the BMJ, but Who Will Notice?

Unknown 1/16/2015 Komentar

As we wrote, most recently last week, the hepatitis C screening and treatment bandwagon keeps rolling along.  There is constant public argument about the prices of treatment regimens, which approach $100,000 per patient...

Baca selengkapnya